The rise of agentic AI is forcing enterprises to confront a new class of security risks. Organizations must secure not just ...

Was your AI chatbot really just agreeing with you all along? A new study shows that several popular AI models are experiencing sycophancy, a tendency to agree with users even when actions are wrong, ...

I test-drove both. Here’s what I learned. In early March, OpenAI unleashed a one-two punch, dropping two major frontier ...

Martial arts robots may play well on stage, but can they get work done? A look at what it takes to deliver the reliability ...

For over a decade, confusion over the size of the proton has held scientists back. Disagreeing measurements of the subatomic particle’s radius meant that scientists couldn’t test one of their key ...

Florida state Rep. Adam Anderson championed the Sunshine Genetics Act, the first state-backed genetic disease screening program in the nation. Anderson's son, Drew, died in 2019 from Tay-Sachs disease ...

The last time we did comparative tests of AI models from OpenAI and Google at Ars was in late 2023, when Google’s offering was still called Bard. In the roughly two years since, a lot has happened in ...

An AI model that learns without human input—by posing interesting queries for itself—might point the way to superintelligence. Save this story Save this story Even the smartest artificial intelligence ...

Google is testing a new image AI model called "Nano Banana 2 Flash," and it's going to be faster than the Nano Banana Pro. This model is part of Gemini's Flash lineup, which is the company's fastest ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...